BE859474A - Composes actifs pour le coeur - Google Patents

Composes actifs pour le coeur

Info

Publication number
BE859474A
BE859474A BE181531A BE181531A BE859474A BE 859474 A BE859474 A BE 859474A BE 181531 A BE181531 A BE 181531A BE 181531 A BE181531 A BE 181531A BE 859474 A BE859474 A BE 859474A
Authority
BE
Belgium
Prior art keywords
heart
active compounds
compounds
active
Prior art date
Application number
BE181531A
Other languages
English (en)
Inventor
E I Carlsson
G B R Samuelsson
B T Lundgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of BE859474A publication Critical patent/BE859474A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pyrrole Compounds (AREA)
BE181531A 1976-10-07 1977-10-07 Composes actifs pour le coeur BE859474A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7611125A SE416545B (sv) 1976-10-07 1976-10-07 Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat

Publications (1)

Publication Number Publication Date
BE859474A true BE859474A (fr) 1978-04-07

Family

ID=20329066

Family Applications (1)

Application Number Title Priority Date Filing Date
BE181531A BE859474A (fr) 1976-10-07 1977-10-07 Composes actifs pour le coeur

Country Status (22)

Country Link
JP (1) JPS5346928A (fr)
AT (1) AT351509B (fr)
AU (1) AU516727B2 (fr)
BE (1) BE859474A (fr)
CA (1) CA1093096A (fr)
CH (1) CH636337A5 (fr)
CS (5) CS208734B2 (fr)
DD (1) DD132195A5 (fr)
DE (1) DE2743493A1 (fr)
DK (1) DK145375C (fr)
FI (1) FI772936A (fr)
FR (1) FR2367054A1 (fr)
GB (1) GB1589838A (fr)
HU (1) HU177638B (fr)
IE (1) IE45938B1 (fr)
LU (1) LU78263A1 (fr)
NL (1) NL7710941A (fr)
NO (1) NO145436C (fr)
NZ (1) NZ185318A (fr)
SE (1) SE416545B (fr)
SU (3) SU735166A3 (fr)
ZA (1) ZA775603B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
JPH0627370B2 (ja) * 1985-08-23 1994-04-13 日本エステル株式会社 ポリエステル異形断面太細糸
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE590054A (fr) * 1959-04-22 1960-10-24 Pfizer Alkylamines et leur préparation.
GB1264128A (fr) * 1968-06-29 1972-02-16
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
ATA702177A (de) 1979-01-15
SU735166A3 (ru) 1980-05-15
SE7611125L (sv) 1978-04-08
NL7710941A (nl) 1978-04-11
CS208730B2 (en) 1981-09-15
NO145436B (no) 1981-12-14
SU959623A3 (ru) 1982-09-15
CA1093096A (fr) 1981-01-06
DK145375C (da) 1983-04-11
DK145375B (da) 1982-11-08
ZA775603B (en) 1978-06-28
FR2367054A1 (fr) 1978-05-05
NZ185318A (en) 1980-02-21
DD132195A5 (de) 1978-09-06
CS208734B2 (en) 1981-09-15
CS208732B2 (en) 1981-09-15
HU177638B (en) 1981-11-28
JPS5346928A (en) 1978-04-27
NO145436C (no) 1982-03-24
NO773406L (no) 1978-04-10
CS208731B2 (en) 1981-09-15
AT351509B (de) 1979-07-25
IE45938L (en) 1978-04-07
LU78263A1 (fr) 1978-06-09
SU784760A3 (ru) 1980-11-30
SE416545B (sv) 1981-01-19
CH636337A5 (en) 1983-05-31
FR2367054B1 (fr) 1981-11-06
CS208733B2 (en) 1981-09-15
DE2743493A1 (de) 1978-04-13
DK443177A (da) 1978-04-08
IE45938B1 (en) 1983-01-12
GB1589838A (en) 1981-05-20
AU2930077A (en) 1979-04-12
FI772936A (fi) 1978-04-08
AU516727B2 (en) 1981-06-18

Similar Documents

Publication Publication Date Title
BE854458A (fr) Composes antihypertensifs
FR2338693A1 (fr) Alese pour literie
MC1171A1 (fr) Composes heterocycliques
IT1085783B (it) Contenitore
BR7707329A (pt) Embarcacao
FR2348493A1 (fr) Immunotest pour la diphenyl-hydantoine
IT1081013B (it) Contenitore
BE857331A (fr) Composes fongicides
AT367700B (de) Behaelter
BE835091A (fr) Composes actifs pour le coeur
SE7700136L (sv) Marineringsbehallare
BE850359A (fr) Composes de 3-indolyl-3-bis-aminophenyl-phtalides
RO75926A (fr) Perfectionnements au container
BE850843A (fr) Composes indolinospiropyrannes
SE7613975L (sv) Container
BE859474A (fr) Composes actifs pour le coeur
IT1084162B (it) Composti silicici polietilenici
IT1077842B (it) Tornio verticale
AT355829B (de) Behaelter
ATA95876A (de) Container
AT364770B (de) Behaelter
SE7706519L (sv) Hopfellbar behallare
SE7703922L (sv) Behallare
BE852536A (fr) Composes organostanniques
IE45688L (en) 2-(dimethylcarbamoylimino)-benzthiazolin-3-carboxylic acid¹esters